Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study

<b>Background.</b> This study aims to determine whether the administration of ferric carboxymaltose (FCM) in patients with acute heart failure (AHF) and iron deficiency (ID) improves morbidity and mortality. <b>Methods.</b> We studied 890 consecutive patients admitted for AHF. Patients were divided...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Raquel López-Vilella, Víctor Donoso Trenado, Pablo Jover Pastor, Ignacio Sánchez-Lázaro, Luis Martínez Dolz, Luis Almenar Bonet
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2022-11-01
Serie:	Life
Ämnen:	acute heart failure iron deficiency ferric carboxymaltose preserved ejection fraction reduced ejection fraction morbidity
Länkar:	https://www.mdpi.com/2075-1729/12/11/1828
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!